Recursion Pharmaceuticals (RXRX) Stock Price
$5.32 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
3 -
Technical
5
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Recursion Pharmaceuticals, AI stock picks, stock alerts and much more.
RXRX AI Stock Analysis
Financial Performance
The company's revenue has seen a significant increase of 226.9% from the previous quarter and a slight increase of 2.3% YoY, indicating an improvement in sales. However, gross profit is in the negative at -$7.1M, which signifies cost inefficiency as it indicates that cost of goods sold exceeds revenues. This situation worsened over time with a YoY decrease by -637.5%. The operating income also saw a sharp decrease both QoQ (-4.1%) and YoY (-90.3%), indicating poor operational efficiency and profitability.
Stock Price & Technical Indicators
The stock price has increased by 11.5% in the last month but decreased by -19.6% YoY, suggesting volatility in its performance over time. The RSI value of 58 suggests that the stock is nearing overbought territory, which could indicate potential for future downward price movement if investors begin to sell off their shares to take profits or avoid losses from perceived overvaluation.
Alternative Data Signals
The company's web traffic decreased slightly MoM (-0.2%), suggesting potentially lower customer engagement or interest online recently compared to prior months while job openings have significantly reduced MoM (-40.6%) and YoY (-38.7%), implying less growth or expansion activities lately.
Around half (52%) of employees reported having a positive business outlook which is neutral but there was an upturn MoM (up by 4%). Social media following on Twitter and Facebook has seen substantial growth in the past three months (+83.% and +48.% respectively), pointing towards growing public interest or awareness about Recursion Pharmaceuticals.
Conclusion
Overall, Recursion Pharmaceuticals' stock performance appears to be bearish. While there are some positive signs such as increased revenue and social media following, the significantly negative gross profit, declining operating income, and reduced job openings suggest potential financial instability and limited growth prospects.
Note: This AI Stock Analysis is based on data as of October 11. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Recursion Pharmaceuticals (RXRX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Recursion Pharmaceuticals (RXRX), currently trading at $5.32, will... Sign up to access price prediction.
About RXRX
-
Recursion Pharmaceuticals, Inc.
-
Symbol
RXRX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
2.3B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$20.36 2.2% |
7 |
 |
Inovio Pharmaceuticals INO |
$2.57 3% |
2 |
 |
Moderna MRNA |
$26.83 2.5% |
4 |
 |
Anavex Life Sciences AVXL |
$9.27 2.6% |
5 |
 |
BridgeBio Pharma BBIO |
$55.49 1.3% |
6 |
News
RXRX Alternative Data
Web Traffic
Recursion Pharmaceuticals receives an estimated 68352 monthly visitors to recursion.com, which is down by -0.2% over the last month.
-
Web Traffic
68352
-
Change from Previous Month
0.2%
-
3 Month Change
0.7%
-
YoY Change
0.7%
Facebook Engagement
Recursion Pharmaceuticals has engaged 21 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
21
-
Daily Change
0%
-
1 Month Change
110%
-
3 Month Change
110%
-
YoY Change
110%
Youtube Subscribers
Recursion Pharmaceuticals has 28,500 subscribers on its main Youtube channel, up by 61% over the last month.
-
Youtube Subscribers
28500
-
Daily Change
2.9%
-
1 Month Change
61%
-
3 Month Change
625.2%
-
YoY Change
625.2%
Job Postings
Recursion Pharmaceuticals has an estimated 19 open job postings, which is down -29.6% over the last month.
-
Job Postings
19
-
Daily Change
0%
-
1 Month Change
29.6%
-
3 Month Change
38.7%
-
YoY Change
38.7%
Reddit Mentions
Recursion Pharmaceuticals has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Recursion Pharmaceuticals has 15,581 Twitter Followers on its main Twitter (also known as X) account, which is up by 1.9% over the last month.
-
Twitter Followers
15581
-
Daily Change
0.1%
-
1 Month Change
1.9%
-
3 Month Change
5.8%
-
YoY Change
5.8%
Reddit Sentiment
The sentiment Score for Recursion Pharmaceuticals is 69 out of 100, which represents a bullish sentiment.
-
Reddit Sentiment
69
Business Outlook
According to employee reviews, the business outlook among employees at Recursion Pharmaceuticals is 52 out of 100 (neutral).
-
Business Outlook
52
-
Change from Previous Month
4%
-
3 Month Change
11.9%
-
YoY Change
11.9%
News Mentions
Recursion Pharmaceuticals was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Recursion Pharmaceuticals has 580 employees.
-
LinkedIn Employees
580
-
Daily Change
2%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
RXRX Financials
RXRX Key Metrics
-
Total Revenue
$14.7M
-
Net Income
-$202.5M
-
Earnings per Share
-$0.5
-
Free cash flow
-$133.8M
-
EBITDA
-$191.4M
-
EBITDA Ratio
-12.9785
-
Total Assets
$1.3B
RXRX 2-year Revenue & Income
RXRX 2-year Free Cash Flow
RXRX Technicals
RXRX SMA
RXRX RSI
FAQ
What's the current price of Recursion Pharmaceuticals (RXRX) Stock?
The price of an Recursion Pharmaceuticals (RXRX) share is $5.32.
What's the market cap of Recursion Pharmaceuticals?
The current market cap of Recursion Pharmaceuticals is 2.3B.
What are some stocks similar to Recursion Pharmaceuticals (RXRX) that investors often compare it to?
Recursion Pharmaceuticals (RXRX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Recursion Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Recursion Pharmaceuticals' stock price to be around $5.33 in 2026. Starting from the current price of $5.32, this represents a 0.2% change in price, indicating a neutral outlook for the stock.
How to buy Recursion Pharmaceuticals (RXRX) Stock?
Recursion Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Recursion Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.